Viral hepatitis and liver infections remain a significant global health concern despite advances in prevention and treatment. Chronic viral hepatitis can lead to progressive liver disease, cirrhosis, and hepatocellular carcinoma if left untreated. Improved screening, vaccination programs, and highly effective antiviral therapies have dramatically changed disease outcomes. However, challenges remain in access to care, early diagnosis, and managing co-infections. This topic highlights advances in antiviral therapy, public health strategies, and global efforts aimed at disease elimination, while addressing emerging challenges in liver infections and long-term liver health.
Title : Gut mucosal immunity and inflammatory bowel disease
Youcun Qian, University of Chinese Academy of Sciences, China
Title : Early and late evaluation of esophageal mucosectomy in surgical treatment of advanced esophageal achalasia
Jose Luis Braga De Aquino, Pontifical Catholic University of Campinas, Brazil
Title : The efficacy of fermented foods as an adjunct therapy in ulcerative colitis - a literature review
Jack D Doorly, Alfred Health, Australia
Title : Professional dining and health
Yaffa Machnes, Bar-Ilan University, Israel
Title : How epigastric impedance would radically change gastric medicine
John Andrew Sutton, Invention City, United States
Title : Differentiating simple and aggressive phenotypes of metabolic dysfunction-associated steatotic liver disease utilizing bioelectrical impedance-derived metabolic age gap
Yury Marakhouski, Belarusian State Medical University, Belarus